Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs12897774 | chr14:74521144 | C/T | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
| PCPG | rs12898548 | chr15:30949394 | G/A | 0 | 177 | 25.87 | 23.43 | 3.17 | KM Plot |
| PCPG | rs12900294 | chr15:30935958 | T/C | 0 | 176 | 25.87 | 21.9 | 3.17 | KM Plot |
| PCPG | rs12904833 | chr15:31090995 | C/T | 1.11E-16 | 174 | 25.92 | 23.83 | 2.12 | KM Plot |
| PCPG | rs12904872 | chr15:31029256 | A/G | 1.11E-16 | 174 | 25.92 | 23.83 | 2.12 | KM Plot |
| PCPG | rs12906190 | chr15:30967896 | C/T | 0 | 174 | 25.92 | 23.83 | 2.12 | KM Plot |
| PCPG | rs12908349 | chr15:43086227 | C/T | 3.35E-14 | 175 | 25.47 | 24.85 | 3.17 | KM Plot |
| PCPG | rs12910799 | chr15:43274864 | G/T | 2.98E-14 | 175 | 25.87 | 24.03 | 3.17 | KM Plot |
| PCPG | rs12911334 | chr15:43305253 | G/A | 2.58E-14 | 176 | 25.87 | 24.03 | 3.17 | KM Plot |
| PCPG | rs12913618 | chr15:43071329 | C/T | 2.96E-13 | 175 | 25.47 | 24.62 | 25.17 | KM Plot |
| PCPG | rs12914380 | chr15:43242268 | C/T | 2.96E-14 | 174 | 25.87 | 24.7 | 3.17 | KM Plot |
| PCPG | rs12915116 | chr15:43074680 | C/T | 1.34E-13 | 178 | 25.87 | 24.62 | 25.17 | KM Plot |
| PCPG | rs12916896 | chr15:30954023 | C/G | 0 | 177 | 25.87 | 23.43 | 3.17 | KM Plot |
| PCPG | rs12919417 | chr16:71579711 | A/G | 0.000121 | 178 | 15.82 | 25.27 | 25.28 | KM Plot |
| PCPG | rs12919804 | chr16:89945369 | G/A | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |